Pay in 4 interest-free payments of $6.70 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
High TSH can be a sign of an underactive thyroid (hypothyroidism) and low TSH can be a sign of an overactive thyroid (hyperthyroidism)
Used for: immune system priming, infection prevention, and rapid recovery
Figures 3df)
Key selective action features: No Growth Hormone Receptor Binding: Does not activate GH receptors responsible for IGF-1 stimulation and systemic growth effects Preserved Glucose Metabolism: No impact on blood sugar regulation, insulin sensitivity, or diabetic risk markers No Tissue Growth Effects: Does not promote muscle hypertrophy, organ growth, or cell proliferation pathways Adipose-Specific Targeting: Works primarily through beta-3 adrenergic receptors concentrated in fat tissue No IGF-1 Elevation: Clinical trials confirmed no changes in serum IGF-1 levels at therapeutic doses Isolated Lipolytic Action: Maintains the fat-breaking properties of growth hormone fragment 176-191 without broader effects Selective Mechanism: Structural differences from full-length GH prevent binding to receptors mediating non-fat-related effects Clinical Validation: Human studies in 900+ participants confirmed selective fat metabolism without systemic hormonal changes The following guide provides detailed analysis of AOD-9604 s selective action and why this selectivity matters for safe, targeted fat metabolism
Hormonal changes during pregnancy can weaken connective tissues, contributing to fluid retention and affecting abdominal muscle support
the risk of stopping treatment may outweigh the theoretical risks to the fetus of continuing
